Clinical Trial Update: Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer [NA]

View source ↗

Summary

This document summarizes a completed clinical trial evaluating gefitinib for metastatic or unresectable head and neck cancer and non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anaplastic Thyroid Cancer, Insular Thyroid Cancer | NA | Status: COMPLETED